后代
怀孕
肠道菌群
肥胖
生物
内分泌学
内科学
丙酸盐
低聚果糖
生理学
断奶
2型糖尿病
糖尿病
医学
免疫学
食品科学
生物化学
遗传学
作者
Junki Miyamoto,Yuna Ando,Akari Nishida,Mayu Yamano,Shunsuke Suzuki,Hiromi Takada,Ikuo Kimura
标识
DOI:10.1002/mnfr.202300758
摘要
Scope Obesity and metabolic diseases are closely associated, and individuals who become obese are also prone to type 2 diabetes and cardiovascular disorders. Gut microbiota is mediated by diet and can influence host metabolism and the incidence of metabolic disorders. Recent studies have suggested that improving gut microbiota through a fructooligosaccharide (FOS)‐supplemented diet may ameliorate obesity and other metabolic disorders. Although accumulating evidence supports the notion of the developmental origins of health and disease, the underlying mechanisms remain obscure. Methods and results ICR mice are fed AIN‐93G formula‐based cellulose –, FOS–, acetate–, or propionate‐supplemented diets during pregnancy. Offspring are reared by conventional ICR foster mothers for 4 weeks; weaned mice are fed high fat diet for 12 weeks and housed individually. The FOS and propionate offspring contribute to suppressing obesity and improving glucose intolerance. Gut microbial compositions in FOS‐fed mothers and their offspring are markedly changed. However, the beneficial effect of FOS diet on the offspring is abolished when antibiotics are administered to pregnant mice. Conclusion The findings highlight the link between the maternal gut environment and the developmental origin of metabolic syndrome in offspring. These results open novel research avenues into preemptive therapies for metabolic disorders by targeting the maternal gut microbiota.
科研通智能强力驱动
Strongly Powered by AbleSci AI